76780-96-6 Usage
Description
2,4-dichloro-6,7,8,9-tetrahydro-5H-cyclohepta[d]pyrimidine, also known as CP-339818, is a synthetic compound belonging to the cyclohepta[d]pyrimidines class. It possesses a molecular formula of C10H10Cl2N2 and has demonstrated potential antitumor and antiviral properties. This chemical has been studied for its ability to inhibit the growth of cancer cells, particularly in ovarian, breast, and prostate cancers, as well as showing promising antiviral activity against human cytomegalovirus (HCMV) and Zika virus.
Uses
Used in Oncology:
2,4-dichloro-6,7,8,9-tetrahydro-5H-cyclohepta[d]pyrimidine is used as an antitumor agent for its potential to inhibit the growth of cancer cells in ovarian, breast, and prostate cancers. Its mechanism of action and efficacy in these cancer types make it a promising candidate for further drug development in oncology.
Used in Virology:
In the field of virology, 2,4-dichloro-6,7,8,9-tetrahydro-5H-cyclohepta[d]pyrimidine is used as an antiviral agent due to its demonstrated activity against human cytomegalovirus (HCMV) and Zika virus. Its potential to combat these viral infections positions it as a candidate for further research and development in antiviral drug discovery.
Check Digit Verification of cas no
The CAS Registry Mumber 76780-96-6 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,6,7,8 and 0 respectively; the second part has 2 digits, 9 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 76780-96:
(7*7)+(6*6)+(5*7)+(4*8)+(3*0)+(2*9)+(1*6)=176
176 % 10 = 6
So 76780-96-6 is a valid CAS Registry Number.
76780-96-6Relevant articles and documents
Pyrimidine derivatives I. Synthesis of hypoglycemic 2-piperazino-5,6-polymethylenepyrimidines 5,6-polymethylenepyrimidines
Sekiya,Hiranuma,Kanayama,Hata
, p. 317 - 322 (2007/10/02)
Synthesis and hypoglycemic activity of 36 novel 2,4-diamino-5,6-polymethylenepyrimidine derivatives are described. Derivatives containing piperazino groups at position 2 showed a potent hypoglycemic activity and concomitantly inhibited platelet aggregation.
